|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Biomedical Sciences, Creighton Unversity, Omaha, NE, USA
2 Research, Department of Veterans Affairs Nebraska Western Iowa Health Care System, Omaha, NE, USA
3 Research, Department of Veterans Affairs Nebraska Western Iowa Health Care System, Omaha, NE, USA; Biomedical Sciences, Creighton Unversity, Omaha, NE, USA
* To whom correspondence should be addressed. E-mail: roger.reidelberger{at}med.va.gov.
Glucagon-like peptide-1(7-36)-amide (GLP-1) is postulated to act as a hormonal signal from gut to brain to inhibit food intake and gastric emptying. A mixed-nutrient meal produces a 2-3 h increase in plasma GLP-1. We determined the effects of intravenous infusions of GLP-1 on food intake, sham feeding, and gastric emptying in rats to assess whether GLP-1 inhibits food intake in part by slowing gastric emptying. A 3-h intravenous infusion of GLP-1 (0.5-170 pmol.kg-1.min-1) at dark onset dose-dependently inhibited food intake in non-food-deprived rats with a potency (mean effective dose) and efficacy (maximal % inhibition) of 23 pmol.kg-1.min-1 and 82%, respectively. Similar total doses of GLP-1 administered over a 15-min period were less potent and effective. In gastric emptying experiments, GLP-1 (1.7-50 pmol.kg-1.min-1) dose-dependently inhibited gastric emptying of saline and ingested chow with potencies of 18 and 6 pmol.kg-1.min-1 and maximal inhibitions of 74 and 83%, respectively. In sham-feeding experiments, GLP-1 (5-50 pmol.kg-1.min-1) dose-dependently reduced 15% aqueous sucrose intake in a similar manner when gastric cannulas were closed (real feeding) and open (sham feeding). These results demonstrate that intravenous infusions of GLP-1 dose-dependently inhibit food intake, sham feeding, and gastric emptying with a similar potency and efficacy. Thus, GLP-1 may inhibit food intake in part by reducing gastric emptying, yet can also inhibit food intake independently of its action to reduce gastric emptying. It remains to be determined whether intravenous doses of GLP-1 that reproduce postprandial increases in plasma GLP-1 are sufficient to inhibit food intake and gastric emptying.
This article has been cited by other articles:
![]() |
K. G. Kumar, L. O. Byerley, J. Volaufova, D. J. Drucker, G. A. Churchill, R. Li, B. York, A. Zuberi, and B. K. S. Richards Genetic variation in Glp1r expression influences the rate of gastric emptying in mice Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R362 - R371. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Chelikani, A. C. Haver, and R. D. Reidelberger Effects of intermittent intraperitoneal infusion of salmon calcitonin on food intake and adiposity in obese rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R1798 - R1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Scott and T. H. Moran The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R983 - R987. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Williams, D. G. Baskin, and M. W. Schwartz Leptin Regulation of the Anorexic Response to Glucagon-Like Peptide-1 Receptor Stimulation Diabetes, December 1, 2006; 55(12): 3387 - 3393. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Chelikani, A. C. Haver, and R. D. Reidelberger Ghrelin Attenuates the Inhibitory Effects of Glucagon-Like Peptide-1 and Peptide YY(3-36) on Food Intake and Gastric Emptying in Rats Diabetes, November 1, 2006; 55(11): 3038 - 3046. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. De Jonghe, A. Hajnal, and M. Covasa Decreased gastric mechanodetection, but preserved gastric emptying, in CCK-1 receptor-deficient OLETF rats Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G640 - G649. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |